NCT02843399 Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy Status COMPLETED Phase N/A
NCT02841579 Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M Status COMPLETED Phase PHASE2
NCT02839889 Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation) Status TERMINATED Phase PHASE4
NCT02835599 Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now Status TERMINATED Phase N/A
NCT02833480 A Study to Investigate the Differential Effects of Inhaled Symbicort and Advair on Lung Microbiota Status UNKNOWN Phase PHASE2
NCT02831257 AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas Status COMPLETED Phase PHASE2
NCT02826525 AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease. Status COMPLETED Phase PHASE1
NCT02826434 Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02822157 Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer Status UNKNOWN Phase PHASE2
NCT02821416 Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics Status COMPLETED Phase PHASE3
NCT02819882 A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC) Status RECRUITING Phase N/A
NCT02814656 Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02814643 Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma Status COMPLETED Phase PHASE3
NCT02811354 Phase II Study of AZD9291 in Advanced Stage NSCLC With EGFR and T790M Mutations Detected in Plasma Ct-DNA Status UNKNOWN Phase PHASE2
NCT02808819 A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist Status COMPLETED Phase PHASE3
NCT02806102 CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction II (COREA-AMI II) Status UNKNOWN Phase N/A
NCT02805361 Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan-for Dapagliflozin in Management of Type II Diabetes Mellitus Status COMPLETED Phase N/A